Today, cancer is a common household word, with each of us closely associated with someone near to us. The incidence of cancer is on a drastic rise in India.1

Every year, dozens of products are released in global markets. In 2012, the US Food and Drug Administration (US FDA) approved 39 new medicines.

Only seven oncology drugs were introduced in India over five years (2010-2014), when nearly 50 breakthrough therapies were rolled out globally.

In India, deaths due to cancer are projected to go up by 20% to over 8.8 lakh in the next four years, according to the Indian Council of Medical Research

Named Patient Program

Governments worldwide have created provisions for granting access to drugs prior to approval for patients who have exhausted all alternative treatment options and do not match clinical trial entry criteria. Often grouped under the labels of compassionate use, expanded access criteria, data collection, promotion, and control of drug distribution. A named patient program can speed uptake after official launch. Physicians, who have had experience before launch, via clinical trials or named patient programs, often become early adopters and references for other physicians once the drug is freely circulating.

Under this Name Patient Medicine Supply, we can help Patients and Doctors to procure these FDA approved Brands from US and Europe in their approved Labeled indications.

These medicines can be import on Prescription and Patient ID on patient name only.

Mr. Neeraj Nagpal

To view all products, please visit our website and submit your queries through mail or call us directly. We will be happy to help you.